Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
International Journal of Spine Surgery|May 14, 2026
Extra-Flaval Lateralized Transforaminal Lumbar Interbody Fusion Using Unilateral Biportal Endoscopy: A Technical Note on How to Maximize Kambin's CorridorMalcolm Darayes Pestonji, Sharvari Gunjotikar, Alexander P L Lewandrowski, et al.
Journal of Personalized Medicine|December 24, 2025
Pharmacoepigenomics in Personalized Medicine: A Hypothesis-Generating Approach to Introduce CpG-PGx SNPs as New Candidates for a Systematic Insight into Genomic-Epigenomic-Phenomic-Pharmacogenomics (G-E-Ph-PGx) AxisAlireza Sharafshah, Kenneth Blum, Kai-Uwe Lewandrowski, et al.
European Journal of Pain (London, England)|May 6, 2026
Sustained Attention Instability as a Cognitive Biomarker in Chronic Spine Pain: A 90-second Visual Attention TestKai-Uwe Lewandrowski, Kenneth Blum, Morgan Lorio, et al.
Psychology Research and Behavior Management|February 19, 2026
Beyond Stigma-Integrating Neurobiology, Genetics, and Awareness Integration Theory in Addiction RecoveryKenneth Blum, Mark S Gold, Nicole Jafari, et al.
Substance Use & Misuse|February 2, 2026
The Emerging Crisis in Non-Prescribed Ketamine Use: A Rapid Attenuation of Depression in Face of Abuse and "Chill-out" or Escapism DrugKai Uwe Lewandrowski, Kenneth Blum, Sergio Schmidt, et al.
Gene & Protein in Disease|August 1, 2025
Exploring dopamine as the master regulator of brain circuitry and mental health genomeKenneth Blum, Eric R Braverman, Alireza Sharafshah, et al.
Frontiers in Public Health|December 3, 2025
Correction: Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergiaKai-Uwe Lewandrowski, Kenneth Blum, Alexander P L Lewandrowski, et al.
Current Pharmaceutical Biotechnology|March 14, 2026
Pharmacogenomic-Based GWAS Meta-Analyses Coupled with Genetic and Epigenetic Liability Testing Connects Facial and Emotional Recognition Systems to Spectrum Disorders, Schizophrenia, Depression, and AnxietyKenneth Blum, Alexander P L Lewandrowski, Alireza Sharafshah, et al.
Journal of Addiction Psychiatry|September 11, 2025
Precision Genomics: A Reality Having Universal Impact in a New Era of Psychiatry - Lessons Learned, Past and PresentKenneth Blum, Alireza Sharafshah, Jag Khalsa, et al.
Research Square|December 3, 2025
Computational GWAS Meta Meta Analysis Revealing Cross Talk Between Cannabis CNR1 and DRD2 Receptors Optimizing Long-Term Outcomes for Cannabis Use Disorder (CUD) By Enhancing Dopamine Homeostasis Promoting High-Quality Cannabis MedicinalsKenneth Blum, Alireza Sharafshah, Jag Khalsa, et al.
Pageof 1